Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 10Pancreatic Neoplasms 9Neoplasm Metastasis 5Breast Neoplasms 5Melanoma 4Colorectal Neoplasms 4Prostatic Neoplasms 3Ovarian Neoplasms 3Lymphoma 3Lung Neoplasms 3Liver Neoplasms 3Carcinoma, Renal Cell 3Wilms Tumor 2Urinary Bladder Neoplasms 2Stomach Neoplasms 2Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Neuroblastoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Kidney Neoplasms 2Astrocytoma 2Adenomatous Polyposis Coli 2Thyroid Neoplasms 1Thrombocytosis 1Somatostatinoma 1Sarcoma, Clear Cell 1Retinoblastoma 1

Interventions

pembrolizumab 6Cisplatin 5Gemcitabine 4Specimen Handling 3Magnetic Resonance Spectroscopy 3Leucovorin 3Hyperthermic Intraperitoneal Chemotherapy 3Carboplatin 3130-nm albumin-bound paclitaxel 3veliparib 2aflibercept 2X-Rays 2Temozolomide 2Taxes 2SS1(dsFv)PE38 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Oxaliplatin 2Nivolumab 2Irinotecan 2Interleukin-12 Subunit p35 2Immunoglobulin G 2Gene Expression Profiling 2Fluorouracil 2Drug Therapy 2Doxorubicin 2Disulfides 2Biopsy 2Bevacizumab 2Albumin-Bound Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fallopian Tube Neoplasms × Sirolimus × Gastrointestinal × Clear all
NCT01010126 2019-01-25

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

National Cancer Institute (NCI)

Phase 2 Completed
252 enrolled 20 charts
GastrointestinalGynecologic

Fallopian Tube Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Somatostatinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡